Stanford, CA3 Active Studies

Organ Transplant Clinical Trials in Stanford, CA

Find 3 actively recruiting organ transplant clinical trials in Stanford, CA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
552
Enrolling

Recruiting Organ Transplant Studies in Stanford

About Organ Transplant Clinical Trials in Stanford

Organ transplantation is a surgical procedure to replace a diseased organ with a healthy one from a donor. Managing rejection through immunosuppressive medications is a lifelong requirement. Research continues to improve outcomes through better immunosuppression, organ preservation, and xenotransplantation.

There are currently 3 organ transplant clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 552 participants. Research is being sponsored by National Institute of Allergy and Infectious Diseases (NIAID), University of Kansas Medical Center, National Heart, Lung, and Blood Institute (NHLBI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Organ Transplant Clinical Trials in Stanford — FAQ

Are there organ transplant clinical trials in Stanford?

Yes, there are 3 organ transplant clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What organ transplant treatments are being tested?

The 3 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for organ transplant.

Data updated October 16, 2026 from ClinicalTrials.gov